Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Rhinosinusitis
Sort By
Newest First
1 / 1
1 / 1
Priority Review
FDA Grants Priority Review to Dupixent for Treatment of Adults with Severe Chronic Rhinosinusitis
Emilie Branch
Pharma's Almanac
PAO-M03-19-NI-017
Mar 12, 2019
